Drugs.com - Pharma Industry News

ASCO: AI Training Improves Accuracy of HER2 Immunohistochemistry Scoring

FRIDAY, May 30, 2025 -- Artificial intelligence (AI)-assisted training improves pathologist accuracy in human epidermal growth factor receptor 2 (HER2) immunohistochemistry (IHC) scoring in patients with breast cancer, according to a study...

May 30, 2025 - 16:10
 0
ASCO: AI Training Improves Accuracy of HER2 Immunohistochemistry Scoring
FRIDAY, May 30, 2025 -- Artificial intelligence (AI)-assisted training improves pathologist accuracy in human epidermal growth factor receptor 2 (HER2) immunohistochemistry (IHC) scoring in patients with breast cancer, according to a study...
Read More

Tags:

Previous Article

ASCO: Encorafenib + Cetuximab + Chemo Lengthens Survival in Metastatic CRC

Next Article

Prevalence of Disability Up Over Twofold for Current Smokers

Related Posts

Hearing Loss Intervention Reduces Social Isolation in Seniors

Hearing Loss Intervention Reduces Social Isolation in S...

May 13, 2025  0

HPV Genome Sequencing Superior in Detecting Head & Neck Cancer

HPV Genome Sequencing Superior in Detecting Head & Neck...

May 30, 2025  0

Artificial Intelligence Flags Interval Breast Cancers Visible at Screening

Artificial Intelligence Flags Interval Breast Cancers V...

May 23, 2025  0